Bosutinib
Bosutinib (rINN/USAN; codenamed SKI-606, marketed under the trade name Bosulif) is a tyrosine kinase inhibitor undergoing research for use in the treatment of cancer. Originally synthesized by Wyeth, it is being developed by Pfizer.
Wikipage redirect
primaryTopic
Bosutinib
Bosutinib (rINN/USAN; codenamed SKI-606, marketed under the trade name Bosulif) is a tyrosine kinase inhibitor undergoing research for use in the treatment of cancer. Originally synthesized by Wyeth, it is being developed by Pfizer.
has abstract
Bosutinib (Firma Pfizer), zuvo ...... orektale Karzinom (Darmkrebs).
@de
Bosutinib (rINN/USAN; codename ...... is being developed by Pfizer.
@en
ボスチニブ（Bosutinib、治験コード：SKI-606、 ...... り創薬され、ファイザーによる買収後、同社で開発が継続された。
@ja
ATC prefix
ATC suffix
CAS number
380843-75-4
ChEBI
FDA UNII code
5018V4AEZ0
IUPAC name
4-[(2,4-dichloro-5-methoxyphen ...... opoxy]quinoline-3-carbonitrile
@en
PubChem
thumbnail
Link from a Wikipage to an external page
Wikipage page ID
17,141,395
Wikipage revision ID
721,969,947
ChEMBL
ChemSpiderID
elimination half-life
excretion
Foecal and renal
IUPHAR ligand
legal US
licence EU
licence US
metabolism
By CYP3A4, to inactive metabolites
molecular weight
5.30446e+2
protein bound
routes of administration
smiles
Clc1cccNc4ccnc3ccccc34
StdInChIKey
UBPYILGKFZZVDX-UHFFFAOYSA-N
tradename
Verifiedfields
verifiedrevid
477,373,749
Watchedfields
subject
hypernym
comment
Bosutinib (Firma Pfizer), zuvo ...... inib gezeigt hatte. Am 27. Mär
@de
Bosutinib (rINN/USAN; codename ...... is being developed by Pfizer.
@en
ボスチニブ（Bosutinib、治験コード：SKI-606、 ...... り創薬され、ファイザーによる買収後、同社で開発が継続された。
@ja
label
Bosutinib
@de
Bosutinib
@en
ボスチニブ
@ja
